The launch of PatroLab is a pivotal milestone, marking a paradigm shift in biologics development and manufacturing
WuXi Biologics has integrated sustainability principles throughout its supplier lifecycle management
The company views ESG reporting as a strategic tool to build trust with clients, investors, regulators, and stakeholders worldwide
This collaboration sets the stage for WuXi Biologics’ first integrated CRDMO center in the region
The site, spanning approximately 25,000 square meters, is expected to commence operations by the end of 2025
WuXi XDC's fully integrated ADC discovery service platform will significantly boost the speed and efficiency of LigaChem's ADC development programs
The CRDMO site will add 120,000L manufacturing capacity to WuXi Biologics’ global network
IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate
Boostimmune will have access to WuXi XDC's fully integrated one-stop bioconjugate platform
Subscribe To Our Newsletter & Stay Updated
